Additional file 3 of The original and two new derivative versions of the COMPERA 2.0 risk assessment model: useful tools for guiding balloon pulmonary angioplasty
Creators: name: Zhang, Yi
name: Li, Xin
name: Jin, Qi
name: Luo, Qin
name: Zhao, Qing
name: Yang, Tao
name: Zeng, Qixian
name: Yan, Lu
name: Duan, Anqi
name: Huang, Zhihua
name: Hu, Meixi
name: Xiong, Changming
name: Zhao, Zhihui
name: Liu, Zhihong
Publisher: name: figshare
Year: 2022
Subjects: subject: Medicine
subject: Physiology
subject: FOS: Biological sciences
subject: Biotechnology
subject: Immunology
subject: FOS: Clinical medicine
subject: Cancer
subject: Science Policy
subject: Mental Health

description: Additional file 3: Table S1. The Scoring of the COMPERA 2.0 3-stratum Prediction Model. Table S2. The Scoring of the COMPERA 2.0 4-stratum Prediction Model. Table S3. Baseline characteristics of all included patients, stratified by the modified COMPERA 2.0 4-stratum. Table S4. Baseline characteristics of all included patients, stratified by the hybrid COMPERA 2.0 4-stratum. Table S5. The incoherence in the risk stratification between the original and modified 3-stratum model. Table S6. The incoherence in the risk stratification between the original and hybrid 3-stratum model. Table S7. The incoherence in risk stratification between the original and modified 4-stratum model. Table S8. The incoherence in risk stratification between the original and hybrid 4-stratum model. Table S9. Correlation between the original COMPERA 4-stratum model and echocardiographic/hemodynamic parameters. Table S10. Correlation between the original COMPERA 3-stratum model and echocardiographic/hemodynamic parameters. Table S11. Correlation between the modified COMPERA 4-stratum model and echocardiographic/hemodynamic parameters. Table S12. Correlation between the modified COMPERA 3-stratum model and echocardiographic/hemodynamic parameters. Table S13. Correlation between the hybrid COMPERA 4-stratum model and echocardiographic/hemodynamic parameters. Table S14. Correlation between the hybrid COMPERA 3-stratum model and echocardiographic/hemodynamic parameters. Table S15. The 1-, 2- and 3-year cumulative clinical worsening-free survival rates after the first BPA session for each stratum. Table S16. Univariate cox analysis of predictive variables of clinical worsening. Table S17. Multivariate cox analysis of predictive variables of clinical worsening. Table S18. Change in risk stratum after the 1st BPA session by risk at baseline (the original 3-stratum model). Table S19. Change in Risk stratum after the 1st BPA session by risk at baseline (original 4-stratum model). Table S20. Change in risk stratum after the 1st BPA session by risk at baseline (the hybrid 3-stratum model). Table S21. Change in risk stratum after the 1st BPA session by risk at baseline with (hybrid 4-stratum model). Table S22. Univariate logistic analysis of variables in predicating reaching low risk after the first BPA session or during subsequent sessions. Table S23. Multivariate logistic analysis of variables in predicating reaching low risk after the first BPA session or during subsequent sessions. Table S24. Univariate logistic analysis of variables in predicating hemodynamic response during subsequent BPA sessions. Table S25. Multivariate logistic analysis of variables in predicating hemodynamic response at follow-up.